CYTK
Price
$35.29
Change
+$1.83 (+5.47%)
Updated
Dec 7, 3:03 PM EST
77 days until earnings call
SANA
Price
$3.90
Change
+$0.05 (+1.30%)
Updated
Dec 7, 3:28 PM EST
98 days until earnings call
Ad is loading...

Analysis and predictions CYTK vs SANA

Header iconCYTK vs SANA Comparison
Open Charts CYTK vs SANABanner chart's image
Cytokinetics
Price$35.29
Change+$1.83 (+5.47%)
Volume$1K
CapitalizationN/A
Sana Biotechnology
Price$3.90
Change+$0.05 (+1.30%)
Volume$1.98K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs SANA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CYTK vs. SANA commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and SANA is a Hold.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (CYTK: $33.43 vs. SANA: $3.84)
Brand notoriety: CYTK and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 84% vs. SANA: 71%
Market capitalization -- CYTK: $3.12B vs. SANA: $835.84M
CYTK [@Biotechnology] is valued at $3.12B. SANA’s [@Biotechnology] market capitalization is $835.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than SANA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 6 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 6 bullish, 2 bearish.
  • SANA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than SANA.

Price Growth

CYTK (@Biotechnology) experienced а +4.01% price change this week, while SANA (@Biotechnology) price change was -8.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.16%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was +25.31%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 22, 2024.

SANA is expected to report earnings on Mar 14, 2024.

Industries' Descriptions

@Biotechnology (+6.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for SANA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($3.12B) has a higher market cap than SANA($836M). SANA YTD gains are higher at: -2.785 vs. CYTK (-27.041). SANA has higher annual earnings (EBITDA): -266.82M vs. CYTK (-462.64M). CYTK has more cash in the bank: 539M vs. SANA (269M). SANA has less debt than CYTK: SANA (96.9M) vs CYTK (748M). CYTK has higher revenues than SANA: CYTK (7.82M) vs SANA (0).
CYTKSANACYTK / SANA
Capitalization3.12B836M373%
EBITDA-462.64M-266.82M173%
Gain YTD-27.041-2.785971%
P/E RatioN/AN/A-
Revenue7.82M0-
Total Cash539M269M200%
Total Debt748M96.9M772%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
68
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKSANA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
73%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HBLAX13.930.02
+0.14%
Hartford Balanced Income A
FCANX11.090.01
+0.09%
Fidelity Advisor Asset Manager® 30% C
NGJAX17.46N/A
N/A
Nuveen Global Real Estate Securities A
LEVIX14.67-0.01
-0.07%
Lazard US Equity Concentrated Instl
PSIAX39.58-0.15
-0.38%
PGIM Quant Solutions Stock Index A

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+2.67%
TVTX - CYTK
57%
Loosely correlated
+5.54%
MDGL - CYTK
50%
Loosely correlated
+0.54%
FATE - CYTK
49%
Loosely correlated
+1.27%
REPL - CYTK
47%
Loosely correlated
+9.04%
VBIV - CYTK
44%
Loosely correlated
+8.81%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with NTLA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
-4.12%
NTLA - SANA
62%
Loosely correlated
-0.17%
BEAM - SANA
61%
Loosely correlated
+1.49%
CRSP - SANA
60%
Loosely correlated
+0.77%
VCYT - SANA
55%
Loosely correlated
+1.14%
EDIT - SANA
55%
Loosely correlated
+1.18%
More